iBeam Technology Discusses Global CRO Cooperation at BioJapan
Pursues collaboration with Shionogi and others on in vivo imaging-based nonclinical research
Confirms 13 follow-up meetings; discusses partnerships with Epsilon Molecular Engineering and others
iBeam Technology is targeting the global pharmaceutical and biotech markets with its contract research organization (CRO) business based on bioimaging.
iBeam Technology said on October 13 that it had participated in BioJapan 2026, held in Yokohama, Japan, from October 7 to 9, where it discussed business cooperation with global pharmaceutical and biotech companies and research institutions. It was the company’s first global event since reorganizing its CRO division in July.
At the event, iBeam Technology secured a total of 13 follow-up meetings, including one with Shionogi, and identified new business opportunities. It discussed potential collaboration on in vivo imaging-based CRO services for central nervous system (CNS) diseases with the department at Shionogi responsible for identifying new technologies and research seeds. The company is also in discussions with two companies, including Epsilon Molecular Engineering (EME), on partnerships and memorandum of understanding (MOU) agreements.
The company reorganized its CRO division to expand its customer base beyond academia into the pharmaceutical, biotech, and medical industries. Its strategy is to combine in vivo live-cell imaging technology with research services to meet global pharmaceutical companies’ demand for nonclinical studies. The company said that this technology, which directly observes cellular changes in vivo, can be used to assess the efficacy and mechanisms of action of drug candidates.
Hot Picks Today
"After Sleeping Well with Strangers"... Who Is the 24-Year-Old Woman Who Won 19 Million Won?
- A "Rich Family's Daughter" Is "Effortlessly Polished" Today, "Glamorous" Tomorrow... Department Store-Core Has 20- and 30-Somethings Going Wild [Why&Next]
- "SK hynix to Hit 4.7 Million Won, Samsung 670,000 Won"... Why Nomura's Bold Forecast justifies it
- "Even Underwear Has to Be Cut Up with Scissors"... China Hit by Rise of "Trash Hunters" in an "If You're Slow, You're Out" Scramble
- "Photos of Kim Jong Un Released by North Korea Are a Deception"... Debate Over Death Rumors Continues
Kim Pilhan, CEO of iBeam Technology, said, "At our first external event since the reorganization, we saw strong interest from global pharmaceutical companies. We will now step up our efforts to expand global sales, leveraging our bioimaging CRO capabilities."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
